Bookbuilding IPO | ₹11 Cr | Listed at NSE SME | Fri, Jun 21, 2024 - Tue, Jun 25, 2024
Medicamen Organics IPO is a book build issue of ₹10.54 crores. The issue is entirely a fresh issue of 0.31 crore shares of ₹10.54 crore.
Medicamen Organics IPO bidding started from Jun 21, 2024 and ended on Jun 25, 2024. The allotment for Medicamen Organics IPO was finalized on Jun 26, 2024. The shares got listed on NSE SME on Jun 28, 2024.
Medicamen Organics IPO price band is set at ₹34 per share. The lot size for an application is 4,000. The minimum amount of investment required by an retail is ₹1,36,000 (4000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (8,000 shares), amounting to ₹2,72,000.
GYR Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Giriraj Stock Broking Pvt.Ltd..
Refer to Medicamen Organics IPO RHP for detailed Information.
IPO Open
Fri, Jun 21, 2024
IPO Close
Tue, Jun 25, 2024
Issue Price
₹34 per share
Market Cap (Pre-IPO)
₹39.78 Cr
| IPO Date | 21 to 25 Jun, 2024 |
| Listed on | Fri, Jun 28, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹32 to ₹34 |
| Issue Price | ₹34 per share |
| Lot Size | 4,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 31,00,000 shares (agg. up to ₹11 Cr) |
| Reserved for Market Maker | 1,72,000 shares Giriraj Stock Broking Pvt.Ltd. (agg. up to ₹0.5848 Cr) |
| Fresh Issue (Ex Market Maker) | 29,28,000 shares (agg. up to ₹10 Cr) |
| Net Offered to Public | 29,28,000 shares (agg. up to ₹10 Cr) |
| Share Holding Pre Issue | 86,00,000 shares |
| Share Holding Post Issue | 1,17,00,000 shares |
| NSE Symbol | MEDIORG |
| ISIN | INE0PE401018 |
Medicamen Organics IPO comprises a total issue size of 31,00,000 shares. The net offer to the public is 29,28,000 shares, after excluding 1,72,000 shares allotted on a firm basis. Of the Net offer 14,60,000 (49.86%) are allocated to QIB, 4,40,000 (15.03%) allocated to NII 10,28,000 (35.11%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 14,60,000 | 49.86% | 47.10% |
| − Anchor Investor Shares Offered | 8,76,000 | 28.26% | |
| − QIB (Ex. Anchor) Shares Offered | 5,84,000 | 18.84% | |
| NII (HNI) Shares Offered | 4,40,000 | 15.03% | 14.19% |
| Retail Shares Offered | 10,28,000 | 35.11% | 33.16% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,72,000 | 5.55% | |
| Total Shares Offered | 31,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 4,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹1,36,000 |
| Retail (Max) | 1 | 4,000 | ₹1,36,000 |
| HNI (Min) | 2 | 8,000 | ₹2,72,000 |
Medicamen Organics IPO raises ₹2.98 crore from anchor investors. Medicamen Organics IPO Anchor bid date is June 20, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Thu, Jun 20, 2024 |
| Shares Offered | 8,76,000 |
| Anchor Portion (₹ Cr.) | 2.98 |
| Anchor lock-in period end date for 50% shares (30 Days) | Fri, Jul 26, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | Tue, Sep 24, 2024 |
Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.
The company's product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).
The company's products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.
The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.
As of September 30, 2023, the company employed a total of 116 people.
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 38.58 | 32.12 | 27.07 | 26.34 |
| Total Income | 25.29 | 22.96 | 21.19 | 25.06 |
| Profit After Tax | 2.40 | 0.96 | 0.09 | 0.30 |
| NET Worth | 15.18 | 8.52 | 7.56 | 7.47 |
| Reserves and Surplus | 6.58 | 2.52 | 1.56 | 1.47 |
| Total Borrowing | 12.66 | 11.80 | 10.25 | 9.59 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of expenses proposed to be incurred towards Product registration in the international markets | 3.00 |
| 2 | Plant updation and increase in production capacity | 2.25 |
| 3 | Funding working capital requirements of our Company | 4.00 |
| 4 | General corporate purpose | 0.39 |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt/Equity | 0.83 |
| RoNW | 15.83 |
| PAT Margin | 9.51% |
| Price to Book Value | 2.39 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 1.11 | 2.21 |
| P/E (x) | 30.53 | 15.41 |
| Promoter Holding | 81.21% | |
| Market Cap | ₹39.78 Cr. |
The Medicamen Organics IPO is subscribed 993.56 times on June 25, 2024 6:19:56 PM (Day 3). The public issue subscribed 1,309.77 times in the retail category, 173.03 times in the QIB category, and 1,343.83 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 173.03 | 5,84,000 | 10,10,52,000 |
| NII* | 1,343.83 | 4,40,000 | 59,12,84,000 |
| Retail | 1,309.77 | 10,28,000 | 1,34,64,44,000 |
| Total | 993.56 | 20,52,000 | 2,03,87,80,000 |
Total Application : 3,36,611
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue Management fees including Merchant Banking fees, Underwriting fees and payment to other intermediaries such as Legal Counsel, Registrars and other out of pocket expenses | 0.78 |
| 2 | Advertising and Marketing Expenses | 0.01 |
| 3 | Fees payable to the stock exchange(s) | 0.05 |
| 4 | 4 Printing & Stationery, Distribution, Postage, etc | 0.01 |
| 5 | Brokerage and Selling Commission | 0.01 |
| 6 | Other Expenses (Banker’s to the Issue, Auditor’s Fees etc.) | 0.03 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹34.00 |
| Open | ₹137.85 |
| Low | ₹130.95 |
| High | ₹144.70 |
| Last Trade | ₹144.70 |
Lead Manager Reports
Medicamen Organics IPO is a SME IPO of 31,00,000 equity shares of the face value of ₹10 aggregating up to ₹11 Crores. The issue is priced at ₹34 per share. The minimum order quantity is 4000.
The IPO opens on Fri, Jun 21, 2024, and closes on Tue, Jun 25, 2024.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Medicamen Organics IPO using UPI as a payment gateway. Zerodha customers can apply in Medicamen Organics IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Medicamen Organics IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Medicamen Organics IPO opens on Fri, Jun 21, 2024 and closes on Tue, Jun 25, 2024.
Medicamen Organics IPO lot size is 4000, and the minimum amount required for application is ₹1,36,000.
You can apply in Medicamen Organics IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Medicamen Organics IPO will be done on Wednesday, June 26, 2024, and the allotted shares will be credited to your demat account by Thu, Jun 27, 2024. Check the Medicamen Organics IPO allotment status.
The Medicamen Organics IPO listing date is on Fri, Jun 28, 2024.
